Unbelievable, but all part of some type of coordinated industry attack that to me is beyond just "shorts". This seems to be more of a monolithic force.

Read More: https://investorshangout.com/post/view?id=585...z6Uu9Y9PaH

________________________

This monolithic force is called BP's "security teams," lobbying networks, moles planted in federal agencies and state legislatures, mainstream media editors and journalists specializing in health/medical issues, etc.

Here's a sales pitch of one of the "security" companies offering its services to BP. One of their services is described as:
_____________________________
Protect the bottom line: In an innovative industry where R&D leads the priority list, lost revenue to counterfeits and other life-threatening incidents, can reduce returns on investment.

https://www.resolver.com/blog/pharmaceutical-...y-threats/
____________________________

Leronlimab is BP's security risk, one of those "life-threatening incidents" that can reduce returns on investment.